Sanofi's “Badge of Honor,” made with FCB Health New York, won gold for Data-Driven Campaign of the Year among suppliers, ...

Sanofi’s ‘A Trusted Circle,’ made with Republica Havas Health, won bronze for Purpose-led Campaign of the Year among ...

Novavax on Thursday provided preliminary adjusted revenue for 2026 and pushed back its profitability target by a year to 2028 ...

Zacks spotlights fresh research on Accenture, Sanofi, and Dell Technologies, revealing trends in consulting, pharma, and ...

Accenture, Sanofi, and Dell Technologies stand out in today's top analyst research picks, each navigating growth and market ...

A recently launched campaign starring patients and scientists shows Sanofi in hot pursuit of scientific innovation. | A ...

The order is limited to Tenblock’s property and requests any new buildings be limited to 33 metres high, or about 10 storeys ...

Sanofi remporte cette année la palme du champion climatique du CAC40, selon une analyse réalisée par Les Ateliers du futur.

Regeneron and Sanofi’s Dupixent trial shows major improvement in allergic fungal rhinosinusitis symptoms in patients 6+. Read ...

The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organization (CDSCO), has approved ...

Sanofi Consumer Healthcare India Limited ( ($IN:SANOFICONR) ) just unveiled an update. Sanofi Consumer Healthcare India Limited announced the ...

ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review Phase ...